Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
clinical trials
life sciences
national blog main
san francisco blog main
3
×
san francisco top stories
amgen
biotech
boston blog main
boston top stories
europe blog main
europe top stories
fda
national
national top stories
new york blog main
new york top stories
abaloparatide
arena pharmaceuticals
boulder/denver blog main
boulder/denver top stories
cancer
cardiovascular disease
cholesterol
colorectal cancer
data
detroit blog main
detroit top stories
eisai
european commission
inclisiran
indiana blog main
indiana top stories
ldl
lorcaserin
lung cancer
mark timney
mt sinai hospital
new york
obsesity
orexigen therapeutics
What
drug
3
×
medicine
marketing
aces
amgen
amgen’s
announced
approval
big
cancer
carries
ceo
cholesterol
developed
eisai
europe
european
fda
flags
flexible
heart
higher
incidence
inclisiran
key
lorcaserin
loss
lowering
market
meant
medco
medicines
nasdaq
nod
open
osteoporosis
passed
patients
post
pricing
Language
unset
3
×
Current search:
medicine���s
×
unset
×
drug
×
" san francisco blog main "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing